Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies

N Engl J Med. 1991 May 9;324(19):1362-5. doi: 10.1056/NEJM199105093241911.

MeSH terms

  • Cost-Benefit Analysis*
  • Drug Industry*
  • Ethics, Professional
  • Prejudice*
  • Research Design
  • United States